Santamaria, Francesca https://orcid.org/0000-0002-9375-7429
Baraldi, Eugenio
Cavalieri, Luca
Cutrera, Renato
La Grutta, Stefania
Piacentini, Giorgio
Siscaro, Gherardo
Funding for this research was provided by:
Chiesi Farmaceutici (Chiesi Farmaceutici)
Article History
Received: 28 November 2025
Accepted: 24 January 2026
First Online: 4 February 2026
Declarations
:
: Not applicable.
: Not applicable.
: F.S. has received fees for lectures from Recordati, AstraZeneca, and Neopharmed. E.B. has received fees for lectures from Sanofi, AstraZeneca, and Chiesi. G.P. has received fees for lectures from Chiesi, Sanofi, Regeneron, AstraZeneca, and GSK. The other authors declare that they have no competing interests.